Berger was the principal founder of Ariad and has served as its chairman and CEO for more than 20 years. Trained initially as a physician, he spent time at Centocor before starting up Ariad out of his home. Nature Biotechnology spoke to him about developing Iclusig, the difference between managing a patient's health and running a company, and how a public entity deals with bad news. http://www.nature.com/nbt/podcast/index.html
Rights and permissions
About this article
Cite this article
First Rounders Podcast: Harvey Berger. Nat Biotechnol 32, 23 (2014). https://doi.org/10.1038/nbt0114-23
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0114-23